SEARCH

SEARCH BY CITATION

References

  • 1
    Novel Swine-Origin Influenza A (H1N1) Virus Investigation Team. Emergence of a novel swine-origin influenza A (H1N1) virus in humans. N Engl J Med 2009; 360:26052615.
  • 2
    Jhung M, Swerdlow D, Olsen S et al. Epidemiology of 2009 Pandemic Influenza A (H1N1) in the United States. Clin Infect Dis 2011; 52(Suppl 1):S13S26.
  • 3
    Thompson WW, Shay DK, Weintraub E et al. Mortality associated with influenza viruses and respiratory syncytial virus in the United States. JAMA 2003; 289:170186.
  • 4
    Centers for Disease Control and Prevention. Prevention and control of seasonal influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2009. MMWR Recomm Rep 2009; 58:154.
  • 5
    Fowlkes A, Arguin P, Biggerstaff M et al. Epidemiology of 2009 Pandemic Influenza A (H1N1) deaths in the United States, April–July 2009. Clin Infect Dis 2011; 52(Suppl 1):860868.
  • 6
    Centers for Disease Control. Flu-related hospitalizations and deaths in the United States from April 2009–January 30, 2010. Available at http://www.cdc.gov/H1N1flu/hosp_deaths_ahdra.htm (Accessed 28 February 2011).
  • 7
    Jhung MA, Davidson H, McIntyre A et al. Preliminary results of 2009 pandemic influenza surveillance in the United States using the aggregate hospitalization and death reporting activity. Influenza Other Respir Viruses 2011; 5:321327.
  • 8
    Lee E, Wu C, Lee E et al. Fatalities associated with the 2009 H1N1 influenza A virus in New York city. Clin Infect Dis 2010; 50:14981504.
  • 9
    Taubenberger J, Morens D. 1918 Influenza: the mother of all pandemics. Emerg Infect Dis 2006; 12:1522.
  • 10
    Centers for Disease Control and Prevention. Prevention and control of influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2010. MMWR Recomm Rep 2010; 59:162.
  • 11
    National Center for Health Statistics. 2000 CDC growth charts: clinical growth charts. Available at http://www.cdc.gov/growthcharts (Accessed 28 February 2011).
  • 12
    Occupational Safety and Health Administration. Guidance on preparing workplaces for an influenza pandemic. OSHA 3327-05R 2009. Available at http://www.osha.gov/Publications/influenza_pandemic.html (Accessed 28 February 2011).
  • 13
    Wilking H, Buda S, vonder Lippe E et al. Mortality of 2009 pandemic influenza A(H1N1) in Germany. Euro Surveill 2010; 15:19741.
  • 14
    Pebody RG, McLean E, Zhao H et al. Pandemic Influenza A(H1N1) 2009 and mortality in the United Kingdom: risk factors for death, April 2009 to March 2010. Euro Surveill 2010; 15:19571.
  • 15
    Correia AM, Queiros L, Dias J. Pandemic influenza A(H1N1) in the North of Portugal: how did the Autumn–Winter wave behave? Rev Port Pneumol 2010; 16:880886.
  • 16
    Hancock K, Veguilla V, Lu X et al. Cross-reactive antibody responses to the 2009 pandemic H1N1 influenza virus. N Engl J Med 2009; 361:19451952.
  • 17
    Skountzou J, Koutsonanos D, Kim J. Immunity to pre-1950 H1N1 influenza viruses confers cross-protection against the pandemic swine-origin 2009 A (H1N1) influenza virus. J Immunol 2010; 185:16421649.
  • 18
    Louie J, Acosta M, Winter K et al. Factors associated with death or hospitalization due to Pandemic 2009 Influenza A (H1N1) infection in California. JAMA 2009; 302:18961902.
  • 19
    Morgan O, Bramley A, Fowlkes A et al. Morbid obesity as a risk factor for hospitalization and death due to 2009 Pandemic influenza A(H1N1) disease. PLoS ONE 2010; 5:e9694.
  • 20
    Ward BW, Barnes PM, Freeman G, Schiller JS. Early release of selected estimates based on data from the 2010 National Health Interview Survey [online]. National Center for Health Statistics. 2011; Available at http://www.cdc.gov/nchs/nhis.htm (Accessed 16 July 2011).
  • 21
    Substance Abuse and Mental Health Services Administration. Results from the 2009 National Survey on Drug Use and Health: Volume I. Summary of National Findings. Rockville, MD: Office of Applied Studies (NSDUH Series H-38A, HHS Publication No. SMA 10-4586Findings), 2010.
  • 22
    Epstein M, Reynaldo S, El-Amin A. Is smoking a risk factor for influenza hospitalization and death? J Infect Dis 2010; 201:794795.
  • 23
    Hanshaoworakul W, Simerman JM, Narueponjirukal U et al. Severe human influenza infections in Thailand: oseltamivir treatment and risk factors for fatal outcome. PLoS ONE 2009; 4:e6051.
  • 24
    McGeer A, Green KA, Plevneshi A et al. Antiviral therapy and outcomes of influenza requiring hospitalization in Ontario, Canada. Clin Infect Dis 2007; 45:15681575.
  • 25
    Centers for Disease Control and Prevention. Antiviral agents for the treatment and chemoprophylaxis of influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 2011; 60:125.
  • 26
    Centers for Disease Control and Prevention. Interim guidance for influenza surveillance: prioritizing RT-PCR testing in laboratories. Available at http://www.cdc.gov/h1n1flu/screening.htm (Accessed 7 April 2010).
  • 27
    Pleis JR, Lucas JW, Ward BW. Summary health statistics for U.S. adults: National Health Interview Survey, 2008. Vital Health Stat 2009; 10:242.
  • 28
    Hirtz D, Thurman DJ, Gwinn-Hardy K et al. How common are the “common” neurologic disorders? Neurology 2007; 68:326337.
  • 29
    Ventura SJ, Abma JC, Mosher WD et al. Estimated pregnancy rates by outcome for the United States, 1990–2004. Natl Vital Stat Rep 2008; 56:126.
  • 30
    Flegel KM, Carroll MD, Ogden CL et al. Prevalence and trends in obesity among US adults, 1999–2008. JAMA 2010; 303:235241.